Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-05

Clinical Trial Update: A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating the safety and efficacy of Oral Armour Thyroid compared with levothyroxine for primary hypothyroidism in adults, cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Armour Thyroid (desiccated thyroid)
  • Levothyroxine (levothyroxine)

Snippet

Sponsor: AbbVie | Conditions: Hypothyroidism | Phase 2, Phase 3 | Status: RECRUITING